Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 12 EP applications Jan Peter Storm has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 17, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11746295

N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS

IPC classification:
A61K 31/445, A61P 35/00, A61P 35/02, C07D 211/22
Applicant:
AstraZeneca AB
Agent:
Multiple attorneys, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Agent:
Lucy Clare Padget, AstraZeneca UK Limited
Status:
The patent has been granted
EP13171373

Optically active 2-aryl cyclopropane carboxamide intermediates

IPC classification:
C07C 233/58
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
The patent has been granted
EP12785416

A PROCESS FOR THE PREPARATION OF BENZYL [(3AS,4R,6S,6AR)-6-HYDROXY-2,2- DIMETHYLTETRAHYDRO-3AH-CYCLOPENTA[D][1,3]DIOXOL]-4-YL]CARBAMATE AND INTERMEDIATES IN THE PROCESS

IPC classification:
C07B 57/00, C07D 317/44
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12735323

N- (6- ( (2R,3S) -3,4-DIHYDROXYBUTAN-2-YLOXY) -2- (4 - FLUOROBENZYLTHIO) PYRIMIDIN- 4 - YL) -3- METHYLAZETIDINE- 1 - SULFONAMIDE AS CHEMOKINE RECEPTOR MODULATOR

IPC classification:
A61K 31/506, C07C 69/92, C07D 205/04, C07D 317/20, C07D 317/24, C07D 403/12
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
GRANT OF PATENT INTENDED
EP11781829

NOVEL COMBINATIONS

IPC classification:
A61K 31/44, A61K 31/58
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12722808

PROCESS

IPC classification:
C07C 309/08, C07D 277/68, C07D 498/10
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13157532

Benzothiazoles as ghrelin receptor modulators

IPC classification:
A61K 31/428, A61P 3/00, C07D 277/82, C07D 417/12, C07D 417/14, C07D 491/08
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13753340

COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS

IPC classification:
A61K 47/48, A61P 1/00, A61P 9/04, A61P 9/12, A61P 13/12, C07D 217/04
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Jan Peter Storm, AstraZeneca AB
Status:
The patent has been granted
EP13753904

COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS

IPC classification:
A61K 47/48, A61P 1/00, A61P 9/04, A61P 9/12, A61P 13/12
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Jan Peter Storm, AstraZeneca AB
Status:
EXAMINATION IN PROGRESS
EP13165585

Phenyl and benzodioxinyl substituted indazole derivatives

IPC classification:
A61K 31/416, A61K 31/4439, A61P 11/00, C07D 231/56, C07D 401/12, C07D 401/14, C07D 403/10, C07D 405/12, C07D 405/14, C07D 409/12, C07D 409/14, C07D 413/12
Applicant:
AstraZeneca AB
Applicant:
Bayer Pharma AG
Agent:
Jan Peter Storm, AstraZeneca PLC
Agent:
Clair Curran, Ropes & Gray International LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11738031

NEW CRISTALLINE FORMS OF N-[2-[[(2,3-DIFLUOROPHENY)METHYL)THIO]-6-{[(1R,2S)-2,3- DIHYDROXY-1-METHYLPROPYL]OXY}-4-PYRIMIDINYL]-1-AZETIDINESULFONAMIDE

IPC classification:
A61K 31/506, C07D 403/12
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
APPLICATION REFUSED
EP15736015

BENZOXAZINONE AMIDES AS MINERALOCORTICOID RECEPTOR MODULATORS

IPC classification:
A61K 31/538, A61P 9/12, C07D 265/36
Applicant:
AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca AB
Agent:
Jan Peter Storm, AstraZeneca PLC
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature